Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjgrens disease
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are…
Idorsia publishes interim results of repurchase offer for its 2025 and 2028 convertible bonds
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – August…
Nyxoah Announces Preliminary Results for the Second Quarter of 2025
Nyxoah Announces Preliminary Results for the Second Quarter of 2025 Mont-Saint-Guibert, Belgium…
Enovix Shareholder Second Reminder: Early Warrant Expiration Price Condition
Enovix Warrants: 14 of 14 Trading Days Above $10.50 August 08, 2025…
GVNR: Unlocking Permissionless, Peer-to-Peer Asset Control Across All Chains
Singapore, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Cross-chain infrastructure has long been…
Lexin Reports Q2 2025 Financial Results: Revenue Hits RMB 3.59B with 15.6% QoQ Growth; Profit Rises for 5 Straight Quarters as Scenario-Based Transactions Surge to Spur Consumption
Shenzhen, China , Aug. 08, 2025 (GLOBE NEWSWIRE) -- On August 7,…
Aja Health and Wellness Inc. Provides Update on Delay in Filing Financial Statements and Implementation of Cease Trade Order
August 08, 2025 18:28 ET | Source: Aja Health and Wellness Inc.…
Ocugen, Inc. Announces $20 Million Registered Direct Offering of Common Stock and Warrants
MALVERN, Pa., Aug. 08, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or…
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 08, 2025 17:00 ET | Source: TELA Bio, Inc. MALVERN, Pa.,…
Folqs Highlights First-Day, Grass-Fed Colostrum Powder Amid Global Surge in Demand
Wilmington, DE, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Folqs, a U.S.-based wellness…
